Asia Pacific Blood Based Biomarkers Market Size & Outlook

The blood based biomarkers market in Asia Pacific is expected to reach a projected revenue of US$ 2,748.7 million by 2030. A compound annual growth rate of 8.3% is expected of Asia Pacific blood based biomarkers market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,759.5
Forecast, 2030 (US$M)
$2,748.7
CAGR, 2025 - 2030
8.3%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific blood based biomarkers market, 2018-2030 (US$M)

Asia Pacific blood based biomarkers market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific blood based biomarkers market highlights

  • The Asia Pacific blood based biomarkers market generated a revenue of USD 1,759.5 million in 2024.
  • The market is expected to grow at a CAGR of 8.3% from 2025 to 2030.
  • In terms of segment, genetic biomarkers was the largest revenue generating type in 2024.
  • Cell-Based Biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.


Asia Pacific data book summary

Market revenue in 2024USD 1,759.5 million
Market revenue in 2030USD 2,748.7 million
Growth rate8.3% (CAGR from 2025 to 2030)
Largest segmentGenetic biomarkers
Fastest growing segmentCell-Based Biomarkers
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGenetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Cell-Based Biomarkers, Epigenetic Biomarkers


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.4% of the global blood based biomarkers market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,748.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood Based Biomarkers Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche Ltd. View profile - - -
Cleveland-Cliffs Inc View profile 28000 200 Public Square, Suite 3300, Cleveland, OH, United States, 44114-2315 https://www.clevelandcliffs.com
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Asia Pacific blood based biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood based biomarkers market will help companies and investors design strategic landscapes.


Genetic biomarkers was the largest segment with a revenue share of 35.47% in 2024. Horizon Databook has segmented the Asia Pacific blood based biomarkers market based on genetic biomarkers, protein biomarkers, metabolic biomarkers, cell-based biomarkers, epigenetic biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.


The Asia-Pacific market is expected to witness the fastest CAGR over the projected period ,driven by increasing healthcare investments, rising awareness of chronic diseases, and improving diagnostic capabilities. 

Growing populations, especially in countries like China and India, are contributing to higher demand for diagnostic solutions in both urban and rural areas. Additionally, the adoption of affordable, rapid diagnostic tests and the expansion of healthcare infrastructure are accelerating market growth in the region.

Reasons to subscribe to Asia Pacific blood based biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific blood based biomarkers market databook

  • Our clientele includes a mix of blood based biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific blood based biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific blood based biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific blood based biomarkers market size, by country, 2018-2030 (US$M)

Asia Pacific Blood Based Biomarkers Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific blood based biomarkers market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online